Search

Displaying all 4 results
DrugBest match

Tasimelteon

go.drugbank.com/drugs/DB09071
ApprovedInvestigational

Tasimelteon is a selective dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (N24HSWD). Occurring commonly in blind individuals without light perception, this condition is often characterized by periods of night-time insomnia and day-time sleepiness. In blind individuals,...

  1. Pathway

    Tasimelteon Drug Metabolism

    smpdb.ca/view/SMP0130834
    Metabolic

    Tasimelteon passes through the liver and is then excreted from the body mainly through the kidney. … Tasimelteon is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.

    Drugs: Tasimelteon
  2. Indication

    Non 24 Hour Sleep Wake Disorder

    go.drugbank.com/conditions/DBCOND0048945
    Drugs: Tasimelteon
  3. Indication

    Sleeping Disorders

    go.drugbank.com/conditions/DBCOND0148601
    Drugs: Amitriptyline · Cinolazepam · Delorazepam · Lormetazepam · Melperone · Mirtazapine +2 more